Compounds > 5-carbamoyl-1h-imidazol-4-yl-piperonylate
Page last updated: 2024-09-03

5-carbamoyl-1h-imidazol-4-yl-piperonylate and pirarubicin

5-carbamoyl-1h-imidazol-4-yl-piperonylate has been researched along with pirarubicin in 1 studies

Compound Research Comparison

Studies
(5-carbamoyl-1h-imidazol-4-yl-piperonylate)		Trials
(5-carbamoyl-1h-imidazol-4-yl-piperonylate)		Recent Studies (post-2010)
(5-carbamoyl-1h-imidazol-4-yl-piperonylate)		Studies
(pirarubicin)		Trials
(pirarubicin)		Recent Studies (post-2010) (pirarubicin)
500810133198

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsukagoshi, S1

Other Studies

1 other study(ies) available for 5-carbamoyl-1h-imidazol-4-yl-piperonylate and pirarubicin

ArticleYear
Overview of new anticancer drugs of interest in Japan.
    Cancer treatment reviews, 1980, Volume: 7, Issue:4

    Topics: Antineoplastic Agents; Doxorubicin; Floxuridine; Humans; Imidazoles; Japan

1980